Endothelial cell-specific over-expression of endothelin-1 leads to more severe cerebral damage following transient middle cerebral artery occlusion

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Leung, Justin W C ^a   Ho, Maggie C Y ^a   Lo, Amy C Y ^a   Chung, Stephen S M ^a   Chung, Sookja K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Infarct; Neurological deficit; Stroke; Transgenic mice

Indexed keywords

COMPLEMENTARY DNA; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN; MESSENGER RNA; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LIGATION; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CELL SECRETION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN; CELL DEATH; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 11144336680     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166277.70538.b0     Document Type: Conference Paper

References (36)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411.
2. Ohlstein EH, Ruffolo RR. Endothelin Receptors: From the Gene to the Human. Boca Raton, FL: CRC Press; 1995.
3. Fuxe K, Tinner B, Staines W, et al. Demonstration and nature of endothelin-3-like immunoreactivity in somatostatin and choline acetyltransferase-immunoreactive nerve cells of the neostriatum of the rat. Neurosci Lett. 1991;123:107.
4. Lee ME, de la Monte SM, Ng SC, et al. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest. 1990;86:141.
5. Nakamura S, Naruse M, Naruse K, et al. Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology. 1993;132:530.
6. Kuwaki T, Kurihara H, Cao WH, et al. Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog Neurobiol. 1997;51:545.
7. Yamashita K, Kataoka Y, Niwa, M, et al. Increased production of endothelins in the hippocampus of stroke-prone spontaneously hypertensive rats following transient forebrain ischemia: histochemical evidence. Cell Mol Neurobiol. 1993;13:15.
8. Jiang MH, Hoog A, Ma KC, et al. Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes. Neuroreport. 1993;4:935.
9. Yamashita K, Niwa M, Kataoka Y, et al. Microglia with an endothelin ETB receptor aggregate in rat hippocampus CA1 subfields following transient forebrain ischemia. J Neurochem. 1994;63:1042.
10. Yamashita K, Kataoka Y, Yamashita YS, et al. Glial endothelin/nitric oxide system participates in hippocampus CA1 neuronal death of SHRSP following transient forebrain ischaemia. Clin Exp Pharmacol Physiol Suppl. 1995;22:S277.
11. Yamashita K, Kataoka Y, Sakurai-Yamashita Y, et al. Involvement of glial endothelin/nitric oxide in delayed neuronal death of rat hippocampus after transient forebrain ischemia. Cell Mol Neurobiol. 2000;20:541.
12. Lampl Y, Fleminger G, Gilad R, et al. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke. 1997;28:1951.
13. Tsang M, Lam KT, Cheung PT, et al. Annual Meeting of the Society for Neuroscience held in San Diego, November 1995. Washington DC: Society for Neuroscience; 1995.
14. Kurihara Y, Kurihara H, Suzuki H, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 1994;368:703.
15. Ho MC, Lo AC, Kurihara H, et al. Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J. 2001;15:618.
16. Hunter AJ, Green AR, Cross AJ. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci. 1995;16:123.
17. Dawson DA, Sugano H, McCarron RM, et al. Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem Res. 1999;24:1499.
18. Clouthier DE, Hosoda K, Richardson JA, et al. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development. 1998;125:813.
19. Koon MH, Chung SM, Chung SK. Experimental Biology held in Orlando, March 2001. Bethesda: Federation of American Societies for Experimental Biology; 2001.
20. Tsang MC, Lo AC, Cheung PT, et al. Perinatal hypoxia-/ischemia-induced endothelin-1 mRNA in astrocyte-like and endothelial cells. Neuroreport. 2001;12:2265.
21. Huang Z, Huang PL, Panahian N, et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883.
22. Korhonen J, Lahtinen I, Halmekyto M, et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood. 1995;86:1828.
23. Robinson MJ, Macrae IM, Todd M, et al. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett. 1990;118:269.
24. Maemura K, Kurihara H, Kurihara Y, et al. Gene expression of endothelin isoforms and receptors in endothelin-1 knock out mice. J Cardiovasc Pharmacol. 1995;26 Suppl:S17-S21.
25. Barone FC, Globus MY, Price WJ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab. 1994;14:337.
26. Bian LG, Zhang TX, Zhao WG, et al. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion. Neurosci Lett. 1994;174:47.
27. Touzani O, Galbraith S, Siegl P, et al. Endothelin-B receptors in cerebral resistance arterioles and their functional significance after focal cerebral ischemia in cats. J Cereb Blood Flow Metab. 1997;17:1157.
28. Touzani O, Roussel S, MacKenzie ET. The ischaemic penumbra. Curr Opin Neurol. 2001;14:83.
29. Macrae IM, Robinson MJ, Graham DI, et al. Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab. 1993;13:276.
30. Patel TR, Galbraith S, Graham DI, et al. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab. 1996;16:950.
31. Matsuo Y, Mihara S, Ninomiya M, et al. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats. Stroke. 2001;32:2143.
32. Bhardwaj A, Wu Y, Hum PD, et al. Administration of selective endothelin receptor type A antagonist Ro 61-1790 does not improve outcome in focal cerebral ischemia in cat. J Cereb Blood Flow Metab. 2000;20:499.
33. Umemura K, Ishiye M, Kosuge K, et al. Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model. Eur J Pharmacol. 1995; 275:17.
34. McAuley MA, Breu V, Graham DI, et al. The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat. Eur J Pharmacol. 1996;307:171.
35. Chuquet J, Benchenane K, Toutain J, et al. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke. 2002;33:3019.
36. Nikolov R, Rami A, Krieglstein J. Endothelin-1 exacerbates focal cerebral ischemia without exerting neurotoxic action in vitro. Eur J Pharmacol. 1993;248:205.